Frontage Holdings Corporation (HKG:1521)
Hong Kong · Delayed Price · Currency is HKD 1.490
+0.175 (13.31%)
Oct 21, 2026, 4:08 PM HKT
Frontage Holdings Market Cap
Frontage Holdings has a market cap or net worth of 3.03 billion as of October 21, 2026. It is the 16,433rd most valuable company in the world and the 729th biggest in Hong Kong. Its market cap has increased by 34.65% in one year.
Market Cap
3.03B
Enterprise Value
3.86B
Revenue
2.18B
Global Rank
Country Rank
#729 Hong Kong
PE Ratio
36.53
ChartMarket Cap Chart
Since May 30, 2019, Frontage Holdings's market cap has decreased from 6.73B to 3.03B, a decrease of -54.94%. That is a compound annual growth rate of -10.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2026 | 3.03B | 49.47% |
| Dec 31, 2025 | 2.03B | -43.71% |
| Dec 31, 2024 | 3.60B | -23.57% |
| Dec 29, 2023 | 4.71B | -20.20% |
| Dec 30, 2022 | 5.91B | -27.11% |
| Dec 31, 2021 | 8.10B | -6.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 30, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Medtide | 2.89B |
| Viva Biotech Holdings | 2.85B |
| Laekna | 2.81B |
| BioDlink International Company | 2.72B |
| HJ Science | 2.57B |
| Jiangsu Recbio Technology | 2.22B |
| Antengene Corporation | 2.12B |
| Mabpharm | 2.06B |